医学分子生物学杂志 ›› 2025, Vol. 22 ›› Issue (6): 594-600.doi: 10.3870/j.issn.1672-8009.2025.06.009

• 论著 • 上一篇    下一篇

肾癌细胞外泌体上调PD-1抑制CD8+T细胞肿瘤杀伤功能

王磊1, 李乾1, 刘鑫2, 刘国路1, 王以金1, 张成波1   

  1. 1徐州医科大学附属淮安医院(淮安市第二人民医院)泌尿外科 江苏省淮安市,223002
    2江苏省军区淮安离职干部休养所门诊部 江苏省淮安市,223002
  • 收稿日期:2025-01-10 出版日期:2025-11-30 发布日期:2025-12-25
  • 通讯作者: 李乾(E-mail:liqian776@163.com)
  • 基金资助:
    淮安市科技项目(No.HAB202117)

Renal Cancer Cell Exosomes Inhibit Tumor Killing Function of CD8+T Cells by Upregulation of PD-1

WANG Lei1, LI Qian1, LIU Xin2, LIU Guolu1, WANG Yijin1, ZHANG Chengbo1   

  1. 1Department of Urology,Huai’an Hospital Affiliated to Xuzhou Medical University(Huai’an Second People’s Hospital),Huai’an,Jiangsu,223002,China
    2Outpatient Department,Retired Cadres Rest and Rehabilitation Center in Huai’an,Huai’an,Jiangsu,223002,China
  • Received:2025-01-10 Online:2025-11-30 Published:2025-12-25
  • Contact: LI Qian(E-mail:liqian776@163.com)
  • Supported by:
    Huai’an Science and Technology Project(No.HAB202117)

摘要: 目的 探究肾癌细胞外泌体调控CD8+T细胞肿瘤杀伤功能。方法 将HK-2 exo、786-O exo、SN12-PM6 exo(10 μg/mL)以及等体积的磷酸盐缓冲溶液(phosphate buffered solution,PBS)与CD8+T细胞共孵育,细胞毒性实验检测杀伤功能,酶联免疫吸附检测(ELISA)测定干扰素-γ(interferon-γ,IFN-γ)、白介素-2(interleukin 2,IL-2)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)浓度,蛋白质印迹检测CD8+T细胞程序性死亡受体1(programmed death-1,PD-1)表达。CD8+T转染PD-1 siRNA(si-PD-1)以及siRNA Negative Control(si-NC)后分别与786-O exo和SN12-PM6 exo共孵育24 h后检测CD8+T细胞对786-O和SN12-PM6细胞杀伤功能。结果 相比于PBS组,786-O exo组、SN12-PM6 exo组CD8+T细胞分泌IFN-γ、IL-2以及TNF-α浓度显著降低(P<0.05),杀伤786-O和SN12-PM6能力显著降低(P<0.05),PD-1蛋白表达显著上调(P<0.05)。而转染si-PD-1的CD8+T细胞与786-O exo和SN12-PM6 exo共孵育后,分泌IFN-γ、IL-2和TNF-α浓度以及杀伤786-O和SN12-PM6的能力均显著高于转染si-NC且与786-O exo和SN12-PM6 exo共孵育后的CD8+T细胞(P<0.05)。结论 肾癌细胞外泌体诱导CD8+T细胞PD-1表达而抑制肿瘤杀伤功能。

关键词: 肾癌, 外泌体, CD8+T细胞, 程序性死亡受体1

Abstract: Objective To investigate the effect of renal cancer cell exosome on CD8+T cell tumor killing fuction. Methods HK-2 exo,786-O exo,SN12-PM6 exo,and an equal volume of PBS were co-cultured with CD8+T cells,cytotoxicity assay was used to detect the killing function of CD8+T cells.ELISA was used to detect the secretion of IFN-γ,IL-2 and TNF-α.Western blotting was used to detect the expression level of PD-1 in CD8+T cells.CD8+T cell transfected PD-1 siRNA(si-PD-1)and siRNA Negative Control(si-NC)were co-incubated with 786-O exo and SN12-PM6 exo for 24 hours,respectively.Cytotoxicity experiments were conducted to detect the cytotoxicity of CD8+T cells against 786-O and SN12-PM6 cells after transfection. Results Compared with those in the PBS group,the secretion of IFN-γ,IL-2 and TNF-α in the 786-O exo group and SN12-PM6 exo group were significantly downregulated(P<0.05).The ability to kill 786-O and SN12-PM6 was significantly reduced(P<0.05),and PD-1 protein expression level was significantly upregulated(P<0.05).After co-incubation with 786-O exo and SN12-PM6 exo,the the secretion of IFN-γ,IL-2 and TNF-α,as well as the ability to kill 786-O and SN12-PM6 were significantly increased when compared with those in the CD8+T cells transfected with si-NC(P<0.05). Conclusion Renal cancer exosome can induce the expression of PD-1 of CD8+T cells to inhibit the tumor killing function.

Key words: renal cancer, exosome, CD8+T cells, programmed death-1

中图分类号: